Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System

Overview of attention for article published in Pharmacoepidemiology & Drug Safety, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 2 news outlets
blogs: 2 blogs

twitter: 7 X users
facebook: 1 Facebook page

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 2 news stories from 2 outlets.

FDA Mini-Sentinel Assessment Confirms Safety and Effectiveness of XARELTO® (rivaroxaban) and its Association with a Lower Risk of Ischemic Stroke vs. Warfarin

2 News, 16 Jan 2018

Information contained on this page is provided by an independent third-party content provider.

FDA Mini-Sentinel Assessment Confirms Safety and Effectiveness of XARELTO® (rivaroxaban) and its Association with a Lower Risk of Ischemic Stroke vs. Warfarin

KTRE, 16 Jan 2018

Information contained on this page is provided by an independent third-party content provider.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.